PATENT CLAIM ANALYSIS

Application Number: 16193045
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-06
Patent Classification: ["424", "133100"]

Abstract:
The present invention relates to methods for treating cancer with apilimod and related compositions and methods.

Claim (Index 36):
The method of  claim 32 , wherein the at least one additional active agent is selected from cyclophosphamide, hydroxydaunorubicin (also referred to as doxorubicin or Adriamycin\u2122) vincristine (also referred to as Oncovin\u2122), prednisone, prednisolone, and combinations thereof.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 98.0
- Lexical Diversity: 1.13333
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15113154', '15213829', '15524844', '15809445', '13968202']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.792313266118879
- 35 USC 102 Novelty (BERT): 0.6111609377227484
- Combined Prediction Score: 0.774198033279266
- Mean Citation Score: 434.80035600000014
- Max Citation Score: 692.62885
- Similarity Product: 461.3335075939298

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test